Insights from 2023 SABCS
W

SABCS 2023 Insights: "Analysis of ctDNA for the Detection of MRD Using a Tissue-Free, Multiomic Assay in Pts With Early Stage Breast Cancer"

By Insights from 2023 SABCS FEATURING Wolfgang Janni
By Insights from 2023 SABCS FEATURING Wolfgang Janni
827 views
January 2, 2024
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
London Breast Meeting

London Breast Meeting 2024

Wed, Sep 4, 2024
05:43
Total Health

Neoadjuvant Chemo for HR+ BC: Year in Review

Feat. C. Ma
17:35
Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino
03:24
ecancer

SABCS 2022 EMERALD Phase 3 Trial: Elacestrant and PFS in ER+/HER2- m…

Feat. V. Kaklamani
02:35
Integrity Continuing Education

SABCS 2023 Summary: "monarchE & NATALEE Trials - Adjuvant T…

Feat. A. Bardia
09:54
Insights from 2023 ESMO Annual Meeting

Newest monarchE Trial Updates Including 5-Year Efficacy Outcomes - A…

Feat. J. Huober
26:30
Insights from 2023 SABCS

SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & H…

Feat. S. Tolaney, H. Rugo
35:14
OncoAlert

Advanced TNBC Updates

Feat. H. Rugo
10:54
Yale Cancer Center

De-Escalation of Adjuvant Therapy in Early Stage HER2+ Breast Cancers

Feat. L. Pusztai
17:57
UChicago Medicine

Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC

Feat. R. Nanda
15:13
Insights from 2023 SABCS

SABCS 2023 Insights: "5-Year Outcomes of the IDEA Trial - ET Wi…

Feat. R. Jagsi
14:15
Insights from 2023 SABCS

SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs.…

Feat. H. Rugo
13:47
Stanford Medicine

HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sen…

Feat. M. Dolezal
14:11
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…

Feat. P. Tarantino
14:11
Total Health

Immune Checkpoint Inhibitors and Neoadjuvant Chemo for HR+ BC: Year …

Feat. C. Ma
07:51
Yale Cancer Center

ctDNA Monitoring of Early Stage Breast Cancer in the Surveillance Se…

Feat. L. Pusztai
14:28
SABCS 2022 Conference Coverage

SABCS 2022 EMERALD Phase 3 Trial Updated Results by Duration of Prio…

Feat. H. Khong
27:52
Insights from 2023 SABCS

SABCS 2023 Insights: "Innovative Approaches at the Diagnosis an…

Feat. J. Mouabbi
24:05
Robert Wesolowski

Clinical Implications of the EMERALD Data on Treatment Outcomes in H…

28:07
Keck School of Medicine of USC

Estrogen Receptor-Targeted PET Imaging: Clinical Applications and In…

Feat. G. Ulaner
12:08
West Cancer Center

Patient Selection for CDK4/6i in HR+/HER2- Advanced BC

Feat. G. Vidal